Companies Complement Therapeutics

Turning powerful new Complement System insights into innovative treatments


Geographic atrophy (late dry age-related macular degeneration) is a chronic eye condition that affects millions – and for which there is currently no available treatment. The disease is related to Complement System disorders.

Cambridge Innovation Capital is a leading Series A investor in the Cambridge ecosystem.

We were born out of a unique relationship with the University of Cambridge and we maintain privileged access to its most inspiring ideas and people in life sciences and deep tech.

Discover more


Read More